Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The James Lind Alliance has supported a priority setting partnership on the surgical treatment of shoulder problems that are important to both patients and clinicians.

 

Professor of Orthopaedic Surgery and Musculoskeletal Science at NDORMS, Jonny Rees led the process which involved both patients and clinicians working together to identify what ‘Research Priorities’ in surgery for common shoulder problems should be addressed.

The aim is to ensure that those who fund health research are made aware of what matters to both patients and clinicians, leading to better evidenced based care through targeted research.

Shoulder pain and loss of shoulder function are very common in the UK, with 4% of people visiting their GP each year. With more and more patients now referred to hospital specialists for surgical treatments, it is important to know which treatments are suitable and what actions to take for a good and fast recovery.

There are also uncertainties about which operations and techniques might be best, and when such operations should be considered over conservative treatment such as physiotherapy.

Professor Jonny Rees says of the process: "Everyone involved in this JLA process found it both a challenging and rewarding experience. Our patients were brilliant and were only too pleased to be engaged in this way to help prioritise shoulder surgery research in the UK. I am very grateful to everyone that spent time helping and contributing to this very worthwhile project".

The British Elbow and Shoulder Society, and the British Orthopaedic Association funded this James Lind Alliance priority setting partnership. The partnership was also supported by and based in the Oxford Biomedical Research Unit and Oxford Biomedical Research Centre.

The partnership identified 10 Research Priorities; you can find them here.

Similar stories

Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease

Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.

Patients like me

What can patients learn from the experiences of people like them who’ve already had a hip replacement? A new tool called ‘Patients like me’ helps answer some of the questions about pain, complications and how long the prosthesis might last.

Study reveals new evidence on rare blood-clotting condition after covid-19 vaccination

Researchers from NDORMS at the University of Oxford have investigated claims that some adenovirus-based COVID-19 vaccines increase the risk of rare blood clots compared to their mRNA-based counterparts.

NDORMS contributes to new UK research to tackle monkeypox outbreak

The UK’s efforts to tackle the monkeypox outbreak will receive a huge boost with the creation of a new research consortium and a new study to study vaccine effectiveness.

World Osteoporosis Day 2022

A bone-healthy lifestyle is vital for strong bones and a mobile, fracture-free future. On World Osteoporosis Day, we are sharing advice from the International Osteoporosis Foundation (IOF), on putting your bone health first.

Mathematician boosts data science research at the Kennedy Institute

Welcome to Yang Luo who has joined the Kennedy Institute as the Principal Investigator of the Luo Group. Her lab is leading the investigation into how genetic variations contribute to diseases of the immune system.